Synchrogenix Transparency Service Case Study: Sponsor A

Sponsor A, a top-10 pharmaceutical company, committed to publishing Clinical Study Reports (CSRs) for clinical outcome trials for all medicines that reached the market, dating back to the formation of the company since its last merger. Sponsor A set an objective to become the most transparent pharmaceutical company in the industry and provide leadership that would ultimately drive transparency across the whole industry.

This resulted in the need to prepare 2000+ reports for disclosure, dating back to December 2000. They prioritized this activity by its top-selling medicines. They issued a press release stating that this would be available on their Clinical Trial Register within an 18-month period.

They also committed to disclosure at the point of “market authorization” or termination of assets once a study had been published for all prospective studies.